在结构的恶化方面,比较猪与牛中关节置换:系统性审查
Sten Kajitani1, Wesley Chorney2, Ahmad Albakri2
1School of Medicine, University College, College Rd, Cork, Ireland. 121115790@umail.ucc.ie.
Journal of cardiothoracic surgery
|November 27, 2025
概括
与牛相比,猪生物假体可以为额头置换 (MVR) 提供更好的长期耐用性,特别是在年轻的患者中. 门的选择应考虑患者的年龄和其他个体因素.
科学领域:
- 心血管外科心血管外科
- 生物材料科学 生物材料科学
- 临床结果研究研究
背景情况:
- 生物假体中置换器 (MVR) 通常使用牛或猪的门.
- 这些门类型之间在结构损 (SVD) 方面的临床优势仍在争论中.
研究的目的:
- 为了直接比较猪和牛生物假体门之间的结构门恶化 (SVD) 在中枢门置换 (MVR) 中.
主要方法:
- 按照PRISMA指南进行系统审查,搜索Embase,MEDLINE和科学网络.
- 包括直接比较MVR中的牛和猪门与报告的SVD结果的队列研究.
- 数据的叙述综合,包括患者人口统计,膜特征和SVD模式;使用纽卡斯尔-太华尺度评估偏差风险.
主要成果:
- 分析了9项研究 (6,945名患者;3.5年至15年的随访).
- 三项研究青猪门,两项青牛门,四项研究没有发现SVD的显著差异.
- 猪的门显示了传单撕裂;牛的门显示了化. 较年轻的患者 (65岁以下) 使用猪的结果更好,这表明猪的耐用性趋向于优越.
结论:
- 选择MVR的门应根据患者的年龄,期望的寿命和风险概况进行个性化选择.
- 在未来的研究中,需要标准化SVD定义和纵向跟踪,以澄清比较耐用性.
相关概念视频
Mitral Valve Prolapse I: Introduction
355
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
355
Mitral Valve Prolapse II: Assessment and Management
389
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
389
Mitral Stenosis III: Medical Management
224
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
224
Mitral Regurgitation I: Introduction
392
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
392
Mitral Regurgitation III: Medical Management
258
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
258
Mitral Stenosis I: Introduction
420
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
420


